South Australian Current Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

CONTROLLED SUBSTANCES (POISONS) REGULATIONS 2011 - REG 18

18—Regulation of prescription drugs—administration of certain S4 drugs (section 18(1d)(a)(iii) of Act)

        (1)         For the purposes of section 18(1d)(a)(iii) of the Act, a dental hygienist, dental therapist, oral health therapist or podiatrist is authorised to administer any of the following S4 drugs:

Articaine

Benzocaine

Bupivacaine

Levobupivacaine

Lignocaine

Mepivacaine

Prilocaine

Ropivacaine.

        (2)         For the purposes of section 18(1d)(a)(iii) of the Act, an optometrist is authorised to administer any of the following S4 drugs:

Eye drops containing 0.5% or less of amethocaine

Eye drops containing 1.0% or less of atropine sulphate

Eye drops containing 1.0% or less of cyclopentolate hydrochloride

Eye drops containing 2.0% or less of homatropine hydrobromide

Eye drops containing 0.5% or less of lignocaine

Eye drops containing 0.5% or less of oxybuprocaine

Eye drops containing 2.0% or less of pilocarpine nitrate

Eye drops containing 0.5% or less of proxymetacaine

Eye drops containing 1.0% or less of tropicamide.

        (3)         For the purposes of section 18(1d)(a)(iii) of the Act, a registered health practitioner of a class determined by the Minister may administer a prescription drug (not being a drug of dependence) to a person if—

            (a)         the registered health practitioner has successfully completed a training program approved by the Minister from time to time for the purposes of this subregulation; and

            (b)         the drug is listed in the Vaccine Administration Code or is a drug approved by the Minister from time to time for the purposes of this subregulation; and

            (c)         the drug is administered as part of—

                  (i)         an immunisation program delivered by—

                        (A)         an incorporated hospital; or

                        (B)         SAAS; or

                        (C)         a council or council subsidiary; or

                  (ii)         an immunisation program delivered by an organisation approved by the Minister for the purposes of this subregulation; and

            (d)         the drug is administered in accordance with—

                  (i)         the Vaccine Administration Code; and

                  (ii)         —

                        (A)         in the case of a drug administered as part of the National Immunisation Program—the National Immunisation Program Schedule and the Australian Immunisation Handbook ; or

                        (B)         in any other case—requirements specified by the Minister.

        (4)         In this regulation—

"Australian Immunisation Handbook" means The Australian Immunisation Handbook published by the Commonwealth Department of Health and Ageing, as in force from time to time;

"National Immunisation Program Schedule" means the National Immunisation Program Schedule published by the Commonwealth Department of Health and Ageing, as in force from time to time.



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback